34.11USD+0.86%Mkt Cap: 581.50M $P/E: —1d ago
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. T…
Industry Peers
Health Information Servicesvs Health Information Services
1M Perf
Lower
$28.83BUSDP/E 31.5
$13.69BUSDP/E 90.6
$10.40BUSD
$7.57BUSDP/E 33.8
$6.42BUSD
$4.87BUSD
$3.94BUSDP/E 30.6
$3.24BUSDP/E 151.4
$2.53BUSD
$1.89BUSDP/E 94.4
$1.53BUSD
$1.30BUSD
$1.21BUSD
$1.02BUSD
$975.39MUSDP/E 48.0
$871.07MUSDP/E Infinity
$796.11MUSDP/E 40.7
$713.43MUSDP/E 33.6
$635.66MUSDP/E 64.3
$609.65MUSD
$563.71MUSDP/E 13.3
$501.65MUSDP/E 28.1
$516.62MUSD
$462.84MUSDP/E 26.3
$486.12MUSDP/E 55.3
$476.60MUSD
$393.13MUSDP/E 90.4
$370.16MUSD
$282.18MUSD
$227.30MUSDP/E 13.9
$213.88MUSDP/E 17.4
$199.74MUSD
$154.92MUSDP/E 30.8
$145.80MUSDP/E 39.3
$152.38MUSD
$147.05MUSD
$134.30MUSDP/E Infinity
$119.30MUSDP/E 26.6
$107.34MUSDP/E 15.9
$90.09MUSDP/E 16.3
$87.68MUSD
$63.42MUSDP/E 11.0
$62.20MUSD
$61.11MUSDP/E 22.1
$48.56MUSDP/E 46.3
$47.87MUSDP/E 57.6
$48.26MUSD
$41.23MUSD
$41.63MUSD
$23.33MUSDP/E 55.8
$23.82MUSDP/E 23.0
$21.92MUSD
$19.31MUSD
$13.45MUSD
$13.16MUSD
$10.93MUSD
$9.67MUSDP/E 14.9
$9.47MUSD
$7.09MUSD
$6.52MUSD
$5.18MUSD
$5.62MUSD
$3.80MUSDP/E Infinity
$3.67MUSDP/E 0.0
$3.46MUSD
$3.38MUSD
$2.99MUSD
$1.44MUSDP/E Infinity
$512.9KUSDP/E 0.0
$373.4KUSD
$165.6KUSD
CRY
GraniteShares YieldBOOST CRCL ETF—
EYES
Corgi Data & Surveillance ETF—P/E 30.5
—
—
—
Indicators:|
Key Statistics
Company
Market Cap581.50M $
Enterprise Value5.30B $
Revenue (TTM)978.76M $
Gross Profit649.05M $
Net Income (TTM)-284.28M $
Revenue/Share59.18 USD
Last Price34.11 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3.0K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)4.99
PEG—
EV/EBITDA9.95
EV/Revenue5.42
P/S0.59
P/B-2.40
EPS (TTM)-17.33
EPS (Forward)6.84
52W Range
11.5036% of range74.07
52W High74.07 USD
52W Low11.50 USD
Profitability
Gross Margin67.23%
Oper. Margin7.55%
EBITDA Margin54.49%
Profit Margin-29.45%
ROE163.47%
ROA-5.82%
Growth
Revenue Growth5.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF117.32M $
CapEx (TTM)129.60M $
FCF Margin11.13%
FCF Yield18.73%
Net Debt4.72B $
Net Debt/EBITDA8.84
Balance Sheet
Debt/Equity-26.54
Current Ratio1.28
Quick Ratio0.93
Book Value/Sh-14.1840 USD
Cash/Share1.251 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:40
Split DateSep 23, 2024
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)36.83 USD
Upside (mean)+8.0%
Target Range22.00 USD – 61.00 USD
$22.00+8.0% to mean$61.00
# Analysts6
Ownership
Shares Out.17.05M
Float5.76M
Insiders7.45%
Institutions91.03%
Short Interest
Short Ratio5.5d
Short % Float11.05%
Short % Out.6.68%
Shares Short1.14M
Short (prev mo.)1.19M
Technical
SMA 5025.81 (+32.1%)
SMA 20034.37 (-0.7%)
Beta0.77
S&P 52W Chg20.05%
Avg Vol (30d)148.18K
Avg Vol (10d)155.22K
Technical Indicators
RSI (14)64.6
MACD2.3435
MACD Signal2.0664
MACD Hist.+0.2771
BB Upper35.18 USD
BB Middle30.04 USD
BB Lower24.90 USD
BB Width34.22%
ATR (14)2.597 USD
Vol Ratio (20d)1.04x